Membranous nephropathy (MN) is a non-inflammatory organ-specific autoimmune disease
which affects the kidney glomerulus, resulting in the formation of immune deposits on the …

Testing for the presence of antinuclear antibodies (ANAs) is a key step in the diagnosis of
systemic lupus erythematosus (SLE) and other systemic autoimmune rheumatic diseases …

Autoantibodies against phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type 1
domain-containing 7A (THSD7A) are emerging as biomarkers to classify membranous …

Autoantibody against phospholipase A2 receptor (anti-PLA2R) is a sensitive and specific
biomarker of idiopathic membranous nephropathy (iMN), being found in approximately 70 …

The diagnostic performance of M-type phospholipase A2 receptor (PLA2R) autoantibodies
and PLA2R glomerular staining in discriminating between idiopathic membranous …

Background Antibodies to M-type phospholipase A2 receptor (a-PLA2R) have been
identified in most patients with idiopathic membranous nephropathy, but the prevalence in …

Membranous nephropathy (MN) is the main cause of adult nephrotic syndrome (NS). The
pathogenesis of MN is complex and involves subepithelial immune complex deposition …

The deposition of IgG4 of antibodies against phospholipase A2 receptor (anti-PLA 2 R) is
predominating in the kidneys of patients with idiopathic membranous nephropathy, while its …

The podocyte injury, and consequent proteinuria, that characterize the pathology of
idiopathic membranous nephropathy (IMN) is mediated by an autoimmune reaction against …

Background Autoantibodies against-phospholipase A2 receptor (PLA2R) are specific
markers of idiopathic membranous nephropathy (iMN). Enzyme-linked immunosorbent …